Diclofenac is the most popular of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) in 15 countries, according to studies, and it is listed as an essential medicine in 74 middle and high income countries, despite its association to heart attack and stroke in vulnerable patients, alerts a study published in PLoS Medicine manazine. This risk, claim the authors,...
Death caused by cardiovascular disease still strikes hard in Argentina. During the last decade, mortality rates from cardiovascular conditions, including infarction, stroke, hypertension and arrhythmia, dropped a mere 6%, according to the registry of vital statistics of de National Health Ministry. In the previous decade, this rate was lower: it had reduced 22%. This difference...
A recent study has shown that hair analysis allows us to evaluate the level of cortisol and stress hormone over a few months while the results from blood tests indicate the status only at the particular time of the test. A rising level of cortisol, like hypertension and excess abdominal fat, increases the risk of...
Eating a Mediterranean diet, enriched with 30 grams of nuts reduces the risk of cardiovascular disease by 30% and decreases the chance of having ictus or stroke by about 49%. The essay, called “Predimed“, is one of the largest clinical nutrition studies ever made in the world and the results will enable a comprehensive nutrition...
Find the coverage of the Congress- May 19 – 22 at the Palais des Congrès in Paris, France The SOLACI@euroPCR Session “Registries and imaging in TAVI and PCI, A Latin American perspective” was held on Wednesday 20th, at 10:30 in Room 342 AB, under the euroPCR Congress 2015. // Read the program If you cannot view...
Original title: Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy. Reference: S.S. Jolly et al. for the TOTAL Investigators. N Engl J Med. 2015 Apr 9;372(15):1389-98. Manual thrombectomy is a routine procedure with ST elevation AMI patients. This common practice proved to reduce mortality in the TAPAS study. However, the TASTE study did not observe...
1. ESTUDIOS DE TECNOLOGIAS EN INTERVENCIONES CORONARIAS • RIBS IV – Presentador: Fernando Alfonso • ABSORB II – Presentador: Patrick Serruys 2. ESTUDIOS DE FARMACOLOGIA EN INTERVENCIONES CORONARIAS • ISAR-TRIPLE – Presentador: Nikolaus Sarafoff • SECURITY – Presentador: Antonio Colombo • BRIGHT – Presentador: Yalin Hang 3. ESTUDIOS EN IMÁGENES CORONARIAS • IVUS-CTO – Presentador:...
Original title: The ABSORB EXTEND Study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. Reference: Alexandre Abizaid et al. EuroIntervention 2015;10:1396-1401. The safety and efficacy of the Absorb Bioresorbable Vascular Scaffold (Absorb BVS) has been previously shown in 131 patients of the ABSORB trial cohorts A and B. Following this trial, the prospective...
Original title: Outcomes of persistent intraoperativa Type Ia endoleak after Standard endovascular aneurysm repair. Reference: Alistair Millen, et al. J. Vasc. Surg 2015;61:1185-91 The purpose of Endovascular Aneurysm Repair (EVAR) in the infrarenal abdominal aortic aneurysms (IAAA) is to prevent growth and rupture. Inadequate proximal seal by the stent favors the presence of leak type 1A that preserves...
Original title: Benefits and Risks of Extended Duration Dual Antiplatelet Therapy after PCI in Patients With and Without Acute Myocardial Infarction. The DAPT Study. Reference: Robert W. Yeh et al. J Am Coll Cardiol. 2015, online before print. The risks and benefits of prolonged antiplatelet therapy after PCI could be different in patients presenting with AMI compared to...